SOS1

CAT # Product Name Tsanangudzo
CPD10000 BI-3406 BI-3406 ine Simba & Inosarudza SOS1 :: KRAS Inhibitor (IC50 = 5 nM), iyo Inovhura Nzira Itsva yeKurapa KRAS-inotyairwa Tumours. BI 3406 inosarudza inosunga kuSOS1 uye inovhara kupindirana neKRAS, zvisinei neKRAS mutation. BI 3406 inokonzeresa RAS GTP uye kuderedzwa kweperK uye inhibits kukura kwesero kweKRAS mutated cell mitsara, inotakura yakawanda yeakajairika KRAS mutations (kureva G12D, G12V, G13D nemamwe). BI 3406, kana inopihwa nemuromo kune bundu rinotakura mbeva, inokonzera dose inotsamira bundu static effect iyo inogona kushandurwa kuita regressions kana yasanganiswa ne MEK1 inhibition.
CPD2807 BAY-293 BAY-293 ine simba SOS1 inhibitor inovhara RAS activation kuburikidza nekukanganisa kweRAS-SOS1 kupindirana. BAY-293) inodzivirira kudyidzana kweKRAS-SOS1 neIC50 ye21 nM uye ikemikari yakakosha yekuferefeta kweramangwana.
...

Taura nesu

Inquiry

Latest News

  • Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

    Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

    Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

  • ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

    ARS-1620: Inhibitor itsva inovimbisa yeK...

    Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

  • AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

    AstraZeneca inogamuchira kukwidziridzwa kwe ...

    AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

WhatsApp Online Chat !